Latest Breaking News On - French financial markets regulator - Page 6 : comparemela.com

Valbiotis Announces Its Combined Shareholders General Meeting Will Be Held on May 2, 2023

Valbiotis Announces Its Combined Shareholders General Meeting Will Be Held on May 2, 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

France generalSeitosei actifinQuai louis prunierEuropean regional development fundPublic affairsResearch developmentEuropean unionInnovative companyCombined shareholders meetingShareholder meetingValbiotis boardSupervisory boardGeneral meetingFrench commercial codeQuebec cityValbiotis universal registration document

Valbiotis Publishes Its 2022 Annual Results and Provides an Update on Its Strategic Roadmap

L’AFP est une agence d’information globale, assurant une couverture rapide, complète et vérifiée des événements de l’actualité comme des thèmes qui façonnent notre quotidien. Avec un réseau de journalistes sans égal, déployé sur 151 pays, l'AFP est en outre un leader mondial de l’investigation nu.

Poitou charentesFrance generalSeitosei actifinEuropean regional development fundLaval university in quebec cityHealth scienceResearch developmentFrench national research agencyBusiness wire incUniversity of clermont auvergnePublic affairsResearch tax creditEuropean unionInnovative companyInstitute on nutritionUnited nations global compact

Valbiotis Publishes Its 2022 Annual Results and Provides an Update on Its Strategic Roadmap

A cash position of more than €20 million at the end of 2022, which provides the Company financial visibility until the end of the first half of 2024; A decisive year on the clinical front

Poitou charentesFrance generalDennis riedlSeitosei actifinEuropean regional development fundLaval university in quebec cityHealth scienceResearch developmentFrench national research agencyPublic affairsUniversity of clermont auvergneResearch tax creditEuropean unionInnovative companyInstitute on nutritionUnited nations global compact

Valbiotis Announces the Last Visit of the Last Patient in the Phase II/III REVERSE-IT Study on TOTUM•63, in Partnership with Nestlé Health Science

The last patient included in the study has completed the final protocol follow-up visit. The first results of the study will be released before the end of the first half of 2023, after the

United statesFrance generalSouth africaUnited arab emiratesNew zealandSaudi arabiaSouth koreaDennis riedlSeitosei actifinEuropean regional development fundHealth scienceResearch developmentHealth nutritionIndustrial affairsPublic affairsEuropean union

Valbiotis Publishes Its Letter to Shareholders and Its 2023 Financial Calendar

Regulatory News: Valbiotis (FR0013254851 ALVAL, PEA SME eligible), a commercially oriented Research and Development company committed to scientific innovation for preventing and combating metabolic

Dennis riedlSeitosei actifinMarc delaunayCarole rocherEuropean regional development fundYoung innovative companyPublic affairsEuropean unionResearch developmentInnovative companyRegulatory newsAnnual general meetingQuebec cityValbiotis universal registration documentFrench financial markets regulatorPublic affairs director